Terms: = Skin cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Clinical Outcome
3 results:
1. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
Wiesner T; He J; Yelensky R; Esteve-Puig R; Botton T; Yeh I; Lipson D; Otto G; Brennan K; Murali R; Garrido M; Miller VA; Ross JS; Berger MF; Sparatta A; Palmedo G; Cerroni L; Busam KJ; Kutzner H; Cronin MT; Stephens PJ; Bastian BC
Nat Commun; 2014; 5():3116. PubMed ID: 24445538
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (alk)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract] [Full Text] [Related]
3. alk-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract] [Full Text] [Related]
